High-dosage human albumin infusion may be superior for hypervolemic hyponatremia in cirrhosis with ascites
High-dosage HA should be superior to low-dosage HA for correcting hypervolemic hyponatremia in cirrhosis, especially in those with a baseline ALB level of <30 g/L, probably due to its significant benefit in the improvement of ALB.
Authors
- Xingshun Qi (ORCID: https://orcid.org/0000-0002-9448-6739)
- Haonan Zhao (ORCID: https://orcid.org/0000-0001-9058-4422)
- Xianxian Zhang (ORCID: https://orcid.org/0000-0003-1238-1341)
- Haitao Zhao (ORCID: https://orcid.org/0000-0002-3444-8044)
- Ran Wang (ORCID: https://orcid.org/0000-0001-6137-9980)
- Lu Chai (ORCID: https://orcid.org/0009-0007-5997-487X)
- Mauro Bernardi
Institutions
- Shenyang Pharmaceutical University (CN)
- Xinjiang Medical University (CN)
- Northern Hospital (AU)
- General Hospital of Shenyang Military Region (CN)
- Command Hospital (IN)
- University of Bologna (IT)
Publication Details
- Journal
- Expert Review of Gastroenterology & Hepatology
- Published
- 2025-11-06
- DOI
- https://doi.org/10.1080/17474124.2025.2587292
- Primary Topic
- Electrolyte and hormonal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00